Liraglutide
SCALE™ Insulin
Novo Nordisk · Phase 3 · Completed · Enrollment 396
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| liraglutide 3.0 mg | 51.8% | 22.77% | n/r | n/r |
| Placebo | 23.98% | 6.55% | n/r | n/r |
Not shown
Every selected arm is drawn.